DrugInfoSys

Ceftriaxone (Na)

Also known as: Ceftriaxone

Drug #146

Ceftriaxone is a third generation, semisynthetic cephalosporin antibiotic. Cephalosporins are derivatives of 7-aminocephalosporic acid and are closely related to penicillins in structure. Cephalosporins have a six membered sulfur containing ring adjoining a ß lactam ring. Ceftriaxone is a broad spectrum, ß lactmase resistant antibiotic effective against a wide range of gram positive and gram negative bacterias. Antibiotics require constant drug level in body for therapeutic effect. This is achieved by taking the medication at regular interval of time throughout the day and night as prescribed. Ceftriaxone (Na) is important to take the drug for the full time period as prescribed. If you discontinue the therapy, it may result in ineffective treatment.

Primary Characteristics

Ceftriaxone (Na) is also known as Ceftriaxone.

It is of Semi Synthetic origin and belongs to Cephalosporin.

It belongs to Peptidoglycan synthesis inhibitor pharmacological group on the basis of mechanism of action and also classified in Antibiotic, Cephalosporin-3rd Gen pharmacological group.

Molecular Weight: 661.6 · Solubility in Water: freely soluble · Solubility in Alcohol: very slightly soluble · Non-proprietary name: Ceftriaxone (Na) · pH: 6.

Molecular structure of Ceftriaxone (Na)

Pharmacokinetics

Distribution: Ceftriaxone (Na) has a volume of distribution is 0.15 l/kg. plasma protein binding is 95%.

Elimination: it is metabolised via hepatic, plasma half-life is 6-9 hr, renal excretion is 40% to 65% excreted unchanged in urine.

Advertisement

Indications

Contraindications

Ceftriaxone (Na) is contraindicated in conditions like Hypersensitivity.

Dosage

Ceftriaxone (Na)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
1 g1 gEvery 24h0.5-2 pre-operatively for prophylaxis against infection in surgery.
0.25 – 0 gIMFor uncompleted Gonnorrhoea
1.5 g1.5 gEvery 24hIV,IMOnce daily or in two divided doses. Max. dose: 4 g/day. Given by IV infusion over atleast 30 minutes.
Paediatric Dosage (20kg)
125 mg125 mgFor prevention of secondary cases of mennigococcal meningitis
35 mg/kg35 mg/kgEvery 24hIntra VenousFor serve infections up to 80mg/kg daily should be given
Neonatal Dosage (3kg)
50 mg/kg50 mg/kgEvery 24hIntra VenousIV doses should be given over 60 min doses above 50mg/kg should be given by IV infusion only

Drug Interactions

1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Ceftriaxone (Na) in overdosage may give rise to further complications which include Eosinophilia , Thrombocytosis , Erythema multiforme , Jaundice , Eosinophilia , Leucopenia, Neutropenia , Erythema multiforme, Jaundice , Biliary pseudolithiasis , Hyperbilirubinemia.

Ceftriaxone (Na) produces potentially life-threatening effects which include Agranulocytosis, Pseudomembranous colitis . Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Ceftriaxone (Na) are Burning sensation.

Ceftriaxone (Na) is known to cause more or less tolerable side effects which are usually transient. These include Diarrhea, Edema, Glossitis, Local pain, Local phlebitis, Loose stools, Maculopapular rash, Nausea, Pruritus , StomatitisX, Urticaria, Vomiting .

Warnings / Precautions

Ceftriaxone should be used with caution in patients with impaired kidney or liver function. Appropriate measure should be taken if secondary infection occurs.

Interference in Pathology

Ceftriaxone (Na) may interfere in the diagnosis of False low reading of urinary glucose testing by Clinitest .

Available Brands

Click on a strength to view available brands.

Multi-Ingredient Combinations

Storage Conditions

Ceftriaxone (Na) should be stored Dry Powder for Inj.

Drug Classification

  1. 1.6.2.1.3Cephalosporins

Manufacturers